Source:http://linkedlifedata.com/resource/pubmed/id/16832342
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
2007-1-19
|
pubmed:abstractText |
Recent studies have identified roles for C/EBPbeta in cellular survival and tumorigenesis, however, the mechanisms through which C/EBPbeta regulates these processes are not fully understood. Previously, we demonstrated that C/EBPbeta(-/-) mice are resistant to carcinogen-induced skin tumorigenesis and in response to topical carcinogen treatment display a 17-fold increase in keratinocyte apoptosis compared to wild-type mice. Here, we have investigated the mechanisms through which C/EBPbeta regulates apoptosis in response to carcinogenic stress. Analysis of carcinogen-treated C/EBPbeta(-/-) mouse skin revealed a striking increase in the number of p53 immunopositive keratinocytes in the epidermis of C/EBPbeta(-/-) mice compared to wild-type mice and this increase was temporally associated with a concomitant anomalous increase in apoptosis. The increased levels of p53 were functional as Mdm2, Bcl-2, C/EBPalpha and p21 were differentially regulated in the epidermis of carcinogen-treated C/EBPbeta(-/-) mice. The increase in p53 protein was not associated with an increase in p53 mRNA levels. To determine whether p53 is required for the increased apoptosis in C/EBPbeta(-/-) mice, C/EBPbeta/p53 compound knockout mice were generated. Carcinogen-treated C/EBPbeta/p53 compound knockout mice did not display increased apoptosis demonstrating p53 is required for the proapoptotic phenotype in C/EBPbeta(-/-) mice. Our results demonstrate that altered keratinocyte survival in C/EBPbeta(-/-) mice results from aberrant regulation of p53 protein and function and indicate C/EBPbeta has a role in the negative regulation of p53 protein levels in response to carcinogen-induced stress.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/9,10-Dimethyl-1,2-benzanthracene,
http://linkedlifedata.com/resource/pubmed/chemical/CCAAT-Enhancer-Binding Protein-beta,
http://linkedlifedata.com/resource/pubmed/chemical/Carcinogens,
http://linkedlifedata.com/resource/pubmed/chemical/Mdm2 protein, mouse,
http://linkedlifedata.com/resource/pubmed/chemical/Proto-Oncogene Proteins c-bcl-2,
http://linkedlifedata.com/resource/pubmed/chemical/Proto-Oncogene Proteins c-mdm2,
http://linkedlifedata.com/resource/pubmed/chemical/Proto-Oncogene Proteins p21(ras),
http://linkedlifedata.com/resource/pubmed/chemical/Tumor Suppressor Protein p53
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0950-9232
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
18
|
pubmed:volume |
26
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
360-7
|
pubmed:dateRevised |
2007-12-3
|
pubmed:meshHeading |
pubmed-meshheading:16832342-9,10-Dimethyl-1,2-benzanthracene,
pubmed-meshheading:16832342-Animals,
pubmed-meshheading:16832342-Apoptosis,
pubmed-meshheading:16832342-CCAAT-Enhancer-Binding Protein-beta,
pubmed-meshheading:16832342-Carcinogens,
pubmed-meshheading:16832342-Cell Survival,
pubmed-meshheading:16832342-Epidermis,
pubmed-meshheading:16832342-Female,
pubmed-meshheading:16832342-Gene Expression Regulation, Neoplastic,
pubmed-meshheading:16832342-Immunoenzyme Techniques,
pubmed-meshheading:16832342-In Situ Nick-End Labeling,
pubmed-meshheading:16832342-Keratinocytes,
pubmed-meshheading:16832342-Male,
pubmed-meshheading:16832342-Mice,
pubmed-meshheading:16832342-Mice, Inbred C57BL,
pubmed-meshheading:16832342-Mice, Knockout,
pubmed-meshheading:16832342-Proto-Oncogene Proteins c-bcl-2,
pubmed-meshheading:16832342-Proto-Oncogene Proteins c-mdm2,
pubmed-meshheading:16832342-Proto-Oncogene Proteins p21(ras),
pubmed-meshheading:16832342-Reverse Transcriptase Polymerase Chain Reaction,
pubmed-meshheading:16832342-Tumor Suppressor Protein p53
|
pubmed:year |
2007
|
pubmed:articleTitle |
Decreased survival of C/EBP beta-deficient keratinocytes is due to aberrant regulation of p53 levels and function.
|
pubmed:affiliation |
Cell Signaling and Cancer Group, Department of Environmental and Molecular Toxicology, North Carolina State University, Raleigh, NC 27695-7633, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, N.I.H., Extramural
|